TNF Pharmaceuticals, Inc.
TNFA
$0.22
$0.02814.58%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -6.99% | 79.83% | 2.39% | -314.62% | -158.46% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 86.19% | -94.27% | -11.84% | 538.63% | 76.51% |
| Change in Net Operating Assets | 128.30% | -966.81% | -28.64% | -84.35% | 1,559.52% |
| Cash from Operations | 78.96% | -36.10% | -39.57% | 1.07% | 38.77% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -64.30% | 128.00% | -1,605.61% | -87.66% | 76.56% |
| Cash from Investing | -64.30% | 128.00% | -1,605.61% | -87.66% | 76.56% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | 100.00% | 17.97% | -- |
| Total Dividends Paid | -- | -- | 100.00% | 21.92% | -- |
| Other Financing Activities | -- | -- | 100.00% | 11.67% | -- |
| Cash from Financing | -212.88% | -91.42% | 1,197.78% | 21.22% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -255.29% | 111.44% | 112.64% | -203.05% | 1,065.13% |